Cholic Acid market size, share & industry analysis, By Method (Folding Ethanol Crystallization Method, Folding Ethyl Acetate Separation Method, Folding Animal Extraction Method, Other), By Application (Organic Acid, Emulsifiers, Detergents, Medicines , Other) and regional Forecast, 2024-2032

Cholic acid, chemically known as 3α,7α,12α-trihydroxy-5β-cholan-24-oic acid is a primary white coloured crystalline bile acid. This is one of the most important bile acid synthesized from cholesterol in liver. It is used to treat patients with bile synthesis disorders that occur due to single enzyme defects, Zellweger syndrome, peroxisomal disorders, and other.

The increasing number of gall stone cases world-wide due to various reasons like obesity, genetic disorder, and other medical conditions shall drive the market for cholic acid. Additionally, the increasing geriatric population is substantially increasing the cases for cholesterol, kidney diseases, and other bile acid related diseases. The extensive research in treatment techniques and medicines shall foster the market.

However, the overdose of cholic acid and its medicines can cause jaundice which can further lead to acute liver injury. This is expected to hinder the market growth.

Market Segmentation:

Based on method, the market is segmented into folding ethanol crystallization method, folding ethyl acetate separation method folding animal extraction, other. Based on application, the market is segmented into organic acid, emulsifier, detergent, medicines, and other.

From a geographical standpoint, the market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Key Players Covered:

The global cholic acid market consists of global & regional players operating. Some of the key players in the market include Dr Falk Pharma, Bruschettini, Zhongshan Belling Biotechnology, Shandong Green Bio-Pharmaceutical, Beijing Yunbang Biosiciences, Anhui Chem-Bright Bioengeneering, DaxingAnLing Snow Lotus Herb Bio-Technology, Industria Chimica Emiliana, Istituto Biologico Chemioterapico, Fujimoto Chemicals, Dipharma Francis SRL, Archer Capital, and others.

Key Insights

• New Advancements in Production Technologies


• Key Trends in the Cholic Acid Market


• New Product Launches, Expansions, Key Players


• Ranking of Key Players in the Market

Regional Analysis:

The market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe is the largest market in terms of value and volume, attributed to the high production of Cholic acid. The large number of manufacturers in the region shall foster the regional market growth. North America is expected to be the fastest growing market attributed to the high R&D in medical and pharmaceutical sector. Asia Pacific is expected to exhibit substantial growth attributed to the increasing number of kidney failure, gall stones and other kidney-related disease cases. Latin America and Middle East and Africa are expected to show considerable growth by the end of the forecast period due to the increasing geriatric population.

Segmentation

Cholic Acid Industry Developments

• In April 2018, Dipharma Francis acquired Kalexsyn Inc., that offers chemical services to the pharmaceutical and biotechnological companies.


• In July 2016, Archer Capital acquired the New Zealand Pharmaceuticals to strengthen its foothold in the region and contribute a considerable share in Cholic acid market.